4.1 Article

The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma

期刊

MOLECULAR BIOSYSTEMS
卷 11, 期 2, 页码 532-539

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c4mb00563e

关键词

-

资金

  1. National Natural Science Foundation of China [81472832, 31471247, 31171271, 31270885, 81302112]
  2. Outstanding Youth Science Foundation of Tongji Hospital [YXQN005]
  3. Youth Sciences and Technology Chenguang Planning of Wuhan [2014070404010219]
  4. Fundamental Research Funds for the Central Universities [2014QN084]

向作者/读者索取更多资源

Emerging evidence indicates that microRNAs (miRNAs) are often dysregulated and play a fundamental role in hepatocellular carcinoma (HCC). However, the mechanism underlying miRNA dysregulation is still elusive. In the present study, we adopted an integrated analysis strategy combining data from genome-wide methylated DNA immunoprecipitation chip and miRNA expression microarray to study the regulation of DNA methylation on miRNA expression in HCC. We first characterized 864 differentially methylated regions (DMRs) located in 236 miRNA regions between cancerous and normal hepatocytes in HCC. We observed that the occurrence of miRNA DNA hypomethylation was more common than its hypermethylation while miRNA DNA hypermethylation was usually found in CpG islands. Then through correlation analysis between miRNA methylation and expression data, we identified 10 dysregulated miRNAs under the potential regulation of DNA methylation in HCC. Five of them (miR-148a, miR-375, miR-195, miR-497 and miR-378) were in hypermethylation and down-regulation status, while another five (miR-106b, miR-25, miR-93, miR-23a and miR-27a) were in hypomethylation and up-regulation status in HCC. Bioinformatics analysis showed that miR-148a may form a negative feedback loop with its targets DNMT1 and DNMT3B and the expression of the miR-195/497 cluster may be affected not only by their hypermethylated promoter region but also by their hypermethylated transcription factors NEUROG2 and DDIT3. Conclusion: our preliminary data and bioinformatics analysis suggest that DNA methylation plays an important and complex role in the regulation of miRNA expression in HCC, which may provide insights into the pathogenesis of HCC and thus may be used for diagnosis and intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma

Hui-Ying Xue, Yong Liu, Jia-Zhi Liao, Ju-Sheng Lin, Bin Li, Wei-Gang Yuan, Robert J. Lee, Lei Li, Chuan-Rui Xu, Xing-Xing He

ONCOTARGET (2016)

Article Nanoscience & Nanotechnology

MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma

Pengxuan Zhao, Shuangping Wu, Yao Cheng, Jia You, Yan Chen, Minsi Li, Chuanchuan He, Xiaojuan Zhang, Tan Yang, Yao Lu, Robert J. Lee, Xingxing He, Guangya Xiang

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)

Review Oncology

The role of autophagy in hepatocellular carcinoma: friend or foe

Lian Liu, Jia-Zhi Liao, Xing-Xing He, Pei-Yuan Li

ONCOTARGET (2017)

Article Medicine, Research & Experimental

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma

Yin-Ping Fan, Jia-Zhi Liao, Ya-Qi Lu, De-An Tian, Feng Ye, Peng-Xuan Zhao, Guang-Ya Xiang, Wang-Xian Tang, Xing-Xing He

MOLECULAR THERAPY-NUCLEIC ACIDS (2017)

Article Medicine, Research & Experimental

The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma

Juan-Feng Zhao, Qiu Zhao, Hui Hu, Jia-Zhi Liao, Ju-Sheng Lin, Chao Xia, Ying Chang, Jing Liu, An-Yuan Guo, Xing-Xing He

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Article Medicine, Research & Experimental

miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer

Fei Xu, Jing-Jun Yan, Yun Gan, Ying Chang, Hong-Ling Wang, Xing-Xing He, Qiu Zhao

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Article Biotechnology & Applied Microbiology

Primary Cilia Blockage Promotes the Malignant Behaviors of Hepatocellular Carcinoma via Induction of Autophagy

Lian Liu, Jia-Qi Sheng, Mu-Ru Wang, Yun Gan, Xiao-Li Wu, Jia-Zhi Liao, De-An Tian, Xing-Xing He, Pei-Yuan Li

BIOMED RESEARCH INTERNATIONAL (2019)

Review Oncology

Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets

Xiang-Yuan Luo, Kong-Ming Wu, Xing-Xing He

Summary: Hepatocellular carcinoma is a deadly health burden worldwide, but recent years have seen significant breakthroughs in new drug development. The FDA has approved multiple drugs for HCC treatment, with over 1000 ongoing clinical trials globally, indicating a vibrant atmosphere in the HCC drug research field.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition

Xiangyuan Luo, Mengdie Cao, Fan Gao, Xingxing He

Summary: YTHDF1 is overexpressed in HCC and associated with HCC grade. It promotes the growth of HCC cells by activating the PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition (EMT) to enhance migration and invasion.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Editorial Material Oncology

Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials

Xing-Xing He, Da-Wei Ye

FRONTIERS IN ONCOLOGY (2022)

Review Oncology

Advances of mRNA vaccine in tumor: a maze of opportunities and challenges

Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao, Xingxing He

Summary: High-frequency mutations in tumor genomes can be utilized to develop tumor vaccines. With advancements in genomics, intelligent algorithms and tumor immunology, it is now possible to target genetic alterations in tumor cells and select vaccine targets efficiently. The application of mRNA in tumor vaccines was initially limited, but the development of mRNA vaccines against SARS-COV-2 has allowed for rapid and cost-effective preparation of tumor mRNA vaccines with good stability and efficiency. This review systematically summarizes the classification and characteristics of tumor antigens, methods for screening neoantigens, vaccine preparation strategies, clinical trial advances, and the main challenges in mRNA tumor vaccine development.

BIOMARKER RESEARCH (2023)

Review Biochemistry & Molecular Biology

Targeting lysosomes in human disease: from basic research to clinical applications

Mengdie Cao, Xiangyuan Luo, Kongming Wu, Xingxing He

Summary: Lysosomes play a crucial role in regulating cellular and organismal homeostasis, with dysfunction associated with the development of various diseases. Understanding the biological functions of lysosomes in different aspects can help elucidate the pathogenesis and treatment strategies of related diseases. Current targeting strategies and corresponding drugs in clinical trials provide direction for further research in targeting lysosomes in human disease.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

The role of YWHAZ in cancer: A maze of opportunities and challenges

Yun Gan, Feng Yee, Xing-Xing He

JOURNAL OF CANCER (2020)

Review Medicine, Research & Experimental

Emerging role of transcription factor-microRNA-target gene feed-forward loops in cancer

Qian Wu, Hua Qin, Qiu Zhao, Xing-Xing He

BIOMEDICAL REPORTS (2015)

暂无数据